Technical Analysis for BHVN - Biohaven Pharmaceutical Holding Company Ltd.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|
| Alert | Time |
|---|---|
| No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock. | |
Free Daily (Stock) Chart Reading
- Earnings date: 05/10/2024
Biohaven Pharmaceutical Holding Company Ltd. Description
Biohaven Pharmaceutical Holding Company Ltd. is a United States-based biopharmaceutical company. The Company is engaged in the identification and development of clinical-stage compounds targeting orphan neurologic indications and other neurological pathways. It has a portfolio of multiple late-stage drug candidates. Its pipeline includes BHV-0223, which is a formulation of a glutamate-modulating agent; BHV-4157, which is a new chemical entity (NCE) that modulates glutamate, and BHV-5000, which is an in-licensed investigational agent of the Company targeting N-Methyl-D-Aspartate (NMDA) receptor antagonism. Its clinical compound, trigriluzole, is indicated for neurodegenerative diseases and cancer indications, among others. Its pipeline also includes BHV-3000 and BHV-3500, which are in-licensed by the Company for a neurologic indication. It focuses on advancing other mechanistic approaches in orphan and neuroscience indications, and is exploring licenses for additional compounds.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Neuroscience Organic Compounds Chemical Compounds Neurodegenerative Diseases Glutamate Neurotransmitters Chemical Entity N Methyl D Aspartic Acid Riluzole
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 62.21 |
| 52 Week Low | 13.535 |
| Average Volume | 1,450,693 |
| 200-Day Moving Average | 36.28 |
| 50-Day Moving Average | 48.12 |
| 20-Day Moving Average | 39.17 |
| 10-Day Moving Average | 38.92 |
| Average True Range | 2.88 |
| RSI (14) | 37.89 |
| ADX | 21.33 |
| +DI | 24.38 |
| -DI | 29.14 |
| Chandelier Exit (Long, 3 ATRs) | 36.97 |
| Chandelier Exit (Short, 3 ATRs) | 42.23 |
| Upper Bollinger Bands | 43.19 |
| Lower Bollinger Band | 35.14 |
| Percent B (%b) | 0.24 |
| BandWidth | 20.55 |
| MACD Line | -2.82 |
| MACD Signal Line | -2.87 |
| MACD Histogram | 0.0473 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 42.08 | ||||
| Resistance 3 (R3) | 42.56 | 41.38 | 41.24 | ||
| Resistance 2 (R2) | 41.38 | 40.11 | 41.14 | 40.96 | |
| Resistance 1 (R1) | 39.23 | 39.32 | 38.64 | 38.75 | 40.69 |
| Pivot Point | 38.05 | 38.05 | 37.76 | 37.81 | 38.05 |
| Support 1 (S1) | 35.90 | 36.78 | 35.31 | 35.42 | 33.47 |
| Support 2 (S2) | 34.72 | 35.99 | 34.48 | 33.20 | |
| Support 3 (S3) | 32.57 | 34.72 | 32.92 | ||
| Support 4 (S4) | 32.09 |
